Tamoxifen Citrate
Inquiry
| Post Date: | Jun 25,2015 |
| Expiry Date: | Jun 24,2016 |
| Detailed Description: |
Cas No. :54965-24-1
Tamoxifen Citrate
Tamoxifen Citrate CAS: 54965-24-1 Tamoxifen Citrate MF: C32H37NO8 Tamoxifen Citrate MW: 563.64 Tamoxifen Citrate EINECS: 259-415-2 Tamoxifen Citrate mp 140-144 °C Tamoxifen Citrate storage temp 2-8°C Tamoxifen Citrate water solubility: slightly soluble Tamoxifen, an anticancer drug, is given to treat breast cancer in women and men. It is used to lower the chance of breast cancer in women with a higher than normal chance of getting breast cancer in the next 5 years (high-risk women). Tamoxifen is also used to treat breast cancer in women after they have finished early treatment. Early treatment can include surgery, radiation, and chemotherapy. Tamoxifen may keep the cancer from spreading to other parts of the body. It may reduce the chance of getting a new breast cancer. In addition, tamoxifen is used to reduce the risk of breast cancer spreading in women who have ductal carcinoma in situ (DCIS) (breast cancer located in the milk ducts and which has not spread) and have already undergone breast cancer surgery and radiation therapy. If u look for Tamoxifen Citrate from here, then good Tamoxifen Citrate is also waiting for u. I am Toni, your trust in my Tamoxifen Citrate is invaluable and priceless to me. My email adress is toni at ycgmp dot com. Tel:86-18872220727 Friends from home and abroad to boost mutual business with collaborative efforts via Tamoxifen Citrate are sincerely welcome. Looking forward to cooperate with u on Tamoxifen Citrate, reliable and trustworthy Tamoxifen Citrate. |
| CAS Registry Number: | 54965-24-1 |
| Synonyms: | ;(z)-2-[4-(1,2-diphenyl-1-butenyl)phenoxyl]-n,n-dimethyl-ethanamine-citrate;1-p-beta-dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene citrate;Tamoxiphen Citrate;2-{4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate (salt); |
| Molecular Formula: | C32H34NO8 |
| Molecular Weight: | 560.6159 |
| Molecular Structure: | 
|
| Hazard Symbols: |  T:Toxic; |
| Risk Codes: | R22:; R45:; |
| Safety Description: | S45:; S53:; |
| Company: | Hulumimi Pharmaceuticals [ China ] |
| Contact: | Toni Zhong |
| Tel: | 027-50756080 |
| Fax: | 0086-27-88048077-794 |
| Email: | toni@ycgmp.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
